Clinical Trial Update: Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) [NA]

View source ↗

Summary

A terminated clinical trial evaluated wound closure therapies for diabetic foot ulcers and venous leg ulcers, comparing a synthetic hybrid-scale fiber matrix to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Venous Leg Ulcer

Drugs mentioned

• Living cellular skin substitute
• Synthetic hybrid-scale fiber matrix

Snippet

Sponsor: Acera Surgical, Inc. | Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer | NA | Status: TERMINATED | Results posted: 2026-02-27